| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.22 | 0.0001 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.19 | 0.0009 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.16 | 0.005 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.006 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.007 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |